On Feb. 11, the Baotou Rare Earth Group, China’s largest rare earth company, announced that on Feb. 9, the People’s Government of the Inner Mongolia Autonomous Region
Fosun Pharm Raises Holding in Tongjitang Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharm, SH: 600196) announcedMarch 10th that it have purchased aggregate 5 388 346 American depositaryshares (ADSs) as of ...Fosun Pharm Raises Holding in Tongjitang Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharm, SH: 600196) announcedMarch 10th that it have purchased aggregate 5 388 346 American depositaryshares (ADSs) as of March 3rd, 2009 in Tongjitang Chinese Medicines Company(NYSE: TCM) via its fully-owned subsidiary Fosun Pharmaceutical (Hong Kong)Limited for US$16.93 million. As a result, Fosun Pharm raised the stake to 15.94% forTCM’s total common shares.展开更多
文摘On Feb. 11, the Baotou Rare Earth Group, China’s largest rare earth company, announced that on Feb. 9, the People’s Government of the Inner Mongolia Autonomous Region
文摘Fosun Pharm Raises Holding in Tongjitang Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharm, SH: 600196) announcedMarch 10th that it have purchased aggregate 5 388 346 American depositaryshares (ADSs) as of March 3rd, 2009 in Tongjitang Chinese Medicines Company(NYSE: TCM) via its fully-owned subsidiary Fosun Pharmaceutical (Hong Kong)Limited for US$16.93 million. As a result, Fosun Pharm raised the stake to 15.94% forTCM’s total common shares.